Niaspan and Vascular calcification - a phase IV clinical study of FDA data
Summary:
Vascular calcification is reported as a side effect among people who take Niaspan (niacin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Cardiac failure congestive.
The phase IV clinical study analyzes which people have Vascular calcification when taking Niaspan. It is created by eHealthMe based on reports of 44,502 people who have side effects when taking Niaspan from the FDA, and is updated regularly.
What is Niaspan?
Niaspan has active ingredients of niacin. It is often used in high blood cholesterol. eHealthMe is studying from 45,453 Niaspan users. Check the latest studies of Niaspan.
What is Vascular calcification?
Vascular calcification (deposits of calcium in the blood vessels) is found to be associated with 389 drugs and 419 conditions by eHealthMe. Check the latest studies of Vascular calcification.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
44,502 people reported to have side effects when taking Niaspan.
Among them, 11 people (0.02%) have Vascular calcification.

Among these 11 people:
How long have people been on Niaspan when they have Vascular calcification? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Vascular calcification when taking Niaspan? *
- female: 27.27 %
- male: 72.73 %
What is the age of people who have Vascular calcification when taking Niaspan? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 10 %
- 40-49: 0.0 %
- 50-59: 10 %
- 60+: 80 %
What are other drugs people take besides Niaspan? *
- Temazepam: 6 people, 54.55%
- Lasix: 6 people, 54.55%
- Zometa: 5 people, 45.45%
- Aspirin: 5 people, 45.45%
- Zocor: 5 people, 45.45%
- Norvasc: 5 people, 45.45%
- Diovan: 5 people, 45.45%
- Glycolax: 4 people, 36.36%
- Nitroglycerin: 4 people, 36.36%
- Lisinopril: 4 people, 36.36%
What are other side effects people have besides Vascular calcification? *
- Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body): 8 people, 72.73%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 72.73%
- Fall: 8 people, 72.73%
- Pain: 7 people, 63.64%
- Anaemia (lack of blood): 7 people, 63.64%
- Pleural Effusion (water on the lungs): 7 people, 63.64%
- Pneumonia: 7 people, 63.64%
- Cardiac Failure Congestive: 7 people, 63.64%
- Hypotension (abnormally low blood pressure): 7 people, 63.64%
- Mitral Valve Incompetence (inefficient heart valve): 7 people, 63.64%
What are the existing conditions these people have? *
- Cardiac Failure Congestive: 3 people, 27.27%
- Multiple Myeloma (cancer of the plasma cells): 2 people, 18.18%
- Neuropathy Peripheral (surface nerve damage): 1 person, 9.09%
- Metastases To Bone (cancer spreads to bone): 1 person, 9.09%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
- Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 9.09%
- Hypercalcaemia (elevated calcium (ca+) level in the blood): 1 person, 9.09%
- High Density Lipoprotein Decreased: 1 person, 9.09%
- Dyslipidaemia (abnormal amount of lipids): 1 person, 9.09%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Niaspan and have Vascular calcification?
- Check whether Vascular calcification is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Niaspan:
- Niaspan (45,453 reports)
Vascular calcification treatments and more:
- Vascular calcification (1,732 reports)
How severe was Vascular calcification and when was it recovered:
Expand to all the drugs that have ingredients of niacin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Niaspan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Vascular calcification:
- Vascular calcification (389 drugs)
Browse all the conditions that are associated with Vascular calcification:
- Vascular calcification (419 conditions)
Related publications that referenced our studies
- Loebl T, Raskin S, "A novel case report: acute manic psychotic episode after treatment with niacin", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
- Loebl T, Raskin S, "A novel case report: acute manic psychotic episode after treatment with niacin", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on niacin (the active ingredients of Niaspan) and Niaspan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zide cause Feeling Cold? - a second ago
- Could Cymbalta cause Peripheral Nerve Injury? - 4 seconds ago
- Could Sildenafil Citrate cause Autoimmune Disorder? - 5 seconds ago
- Could Cutivate cause Weakness? - 6 seconds ago
- Could Crestor cause Urethral Pain? - 20 seconds ago
- Xeljanz Xr and Stomachache for Women aged 40-49 - 22 seconds ago
- Xeljanz Xr and Stomach Pain for Women aged 40-49 - 23 seconds ago
- Xeljanz Xr and Pain - Abdomen for Women aged 40-49 - 23 seconds ago
- Xeljanz Xr and Belly Ache for Women aged 40-49 - 23 seconds ago
- Xeljanz Xr and Abdominal Cramps for Women aged 40-49 - 23 seconds ago